Arya Bikas K, Khan Tila, Das Ranjan Saurav, Guha Rajlakshmi, Das Bhattacharya Sangeeta
School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
Centre for Educational Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
Hum Vaccin Immunother. 2021 Jul 3;17(7):2036-2042. doi: 10.1080/21645515.2020.1851535. Epub 2021 Feb 5.
Children living with Human Immunodeficiency virus (HIV; CLH) have special vaccine needs. Determinants of household-level uptake of vaccines need to be examined in high-risk families with CLH. We previously conducted a study on the impact of type b conjugate vaccine and pneumococcal conjugate vaccine (PCV-13) in 125 HIV-affected families and 47 HIV-unaffected families in West Bengal. We then interviewed 99 of these 172 families who had participated in the study to understand the household-level factors that determine vaccine uptake. Sixty-four of the 99 families had one or more CLH. Within these 64 families, 30% of CLH had missed vaccines under the universal immunization program (UIP), compared to only 6% of HIV-uninfected children (HUC) ( = .001). Maternal HIV positivity in a family increased risk of missing UIP vaccines nearly five times (4.82, = .001). Almost all families accessed UIP vaccines at local primary vaccination centers, but 14% of families experienced stigma due to HIV and avoided getting one or more vaccine doses. In contrast, in our study, 100% of HIV-affected families actively sought PCV-13 and HibCV, despite having to travel. Factors that influenced uptake included awareness generation and activation by an outreach worker and availability of vaccines on pick-up days for anti-retroviral therapy. Eighty-six percent of families strongly recommended PCV-13 to other families. To conclude, while we found that CLH have barriers to getting vaccinations, a program designed to take into consideration the obstacles that HIV-affected families face showed a high rate of vaccine uptake.
感染人类免疫缺陷病毒(HIV)的儿童(CLH)有特殊的疫苗需求。需要在有CLH的高危家庭中研究家庭层面疫苗接种的决定因素。我们之前在西孟加拉邦对125个受HIV影响的家庭和47个未受HIV影响的家庭进行了一项关于b型结合疫苗和肺炎球菌结合疫苗(PCV - 13)影响的研究。然后,我们采访了参与该研究的这172个家庭中的99个,以了解决定疫苗接种的家庭层面因素。这99个家庭中有64个有一个或多个CLH。在这64个家庭中,30%的CLH在扩大免疫规划(UIP)下错过疫苗接种,而未感染HIV的儿童(HUC)中这一比例仅为6%(P = 0.001)。家庭中母亲HIV呈阳性使错过UIP疫苗的风险增加近五倍(4.82,P = 0.001)。几乎所有家庭都在当地的初级疫苗接种中心接种UIP疫苗,但14%的家庭因HIV受到污名化,从而避免接种一剂或多剂疫苗。相比之下,在我们的研究中,100%受HIV影响的家庭尽管需要出行,仍积极寻求接种PCV - 13和HibCV。影响接种的因素包括外展工作者的宣传和动员以及在抗逆转录病毒治疗取药日有疫苗供应。86%的家庭强烈向其他家庭推荐PCV - 13。总之,虽然我们发现CLH在接种疫苗方面存在障碍,但一个考虑到受HIV影响家庭所面临障碍的项目显示出很高的疫苗接种率。